Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks significant expression of estrogen receptor, progesterone receptor, and HER2. Patients with locally advanced or metastatic TNBC benefit from treatment with atezolizumab, a humanized monoclonal anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Bockstal, Mieke R., Cooks, Maxine, Nederlof, Iris, Brinkhuis, Mariël, Dutman, Annemiek, Koopmans, Monique, Kooreman, Loes, van der Vegt, Bert, Verhoog, Leon, Vreuls, Celine, Westenend, Pieter, Kok, Marleen, van Diest, Paul J., Nauwelaers, Inne, Laudus, Nele, Denkert, Carsten, Rimm, David, Siziopikou, Kalliopi P., Ely, Scott, Zardavas, Dimitrios, Roberts, Mustimbo, Floris, Giuseppe, Hartman, Johan, Acs, Balazs, Peeters, Dieter, Bartlett, John M.S., Dequeker, Els, Salgado, Roberto, Giudici, Fabiola, Michiels, Stefan, Horlings, Hugo, van Deurzen, Carolien H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507620/
https://www.ncbi.nlm.nih.gov/pubmed/34638394
http://dx.doi.org/10.3390/cancers13194910

Ejemplares similares

Ejemplares similares